168 related articles for article (PubMed ID: 2971274)
1. Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.
Rafferty P; Beasley R; Holgate ST
Thorax; 1988 Jun; 43(6):446-50. PubMed ID: 2971274
[TBL] [Abstract][Full Text] [Related]
2. Comparison of preservative-free and preservative-containing ipratropium bromide.
Henry RL; Hankin RG; Abramson R
Aust Paediatr J; 1989 Apr; 25(2):86-8. PubMed ID: 2525377
[TBL] [Abstract][Full Text] [Related]
3. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.
Beasley CR; Rafferty P; Holgate ST
Br Med J (Clin Res Ed); 1987 May; 294(6581):1197-8. PubMed ID: 2954609
[No Abstract] [Full Text] [Related]
4. The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma.
Miszkiel KA; Beasley R; Holgate ST
Br J Clin Pharmacol; 1988 Sep; 26(3):295-301. PubMed ID: 2972308
[TBL] [Abstract][Full Text] [Related]
5. Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma.
Bryant DH; Rogers P
Chest; 1992 Sep; 102(3):742-7. PubMed ID: 1387604
[TBL] [Abstract][Full Text] [Related]
6. Preservatives in nebulizer solutions: risks without benefit.
Beasley R; Fishwick D; Miles JF; Hendeles L
Pharmacotherapy; 1998; 18(1):130-9. PubMed ID: 9469687
[TBL] [Abstract][Full Text] [Related]
7. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide.
O'Callaghan C; Milner AD; Swarbrick A
BMJ; 1989 Dec; 299(6713):1433-4. PubMed ID: 2532940
[No Abstract] [Full Text] [Related]
9. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
[TBL] [Abstract][Full Text] [Related]
10. Effect of inhaled preservatives on asthmatic subjects. II. Benzalkonium chloride.
Zhang YG; Wright WJ; Tam WK; Nguyen-Dang TH; Salome CM; Woolcock AJ
Am Rev Respir Dis; 1990 Jun; 141(6):1405-8. PubMed ID: 2140930
[TBL] [Abstract][Full Text] [Related]
11. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
Friberg S; Graff-Lonnevig V
Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
[TBL] [Abstract][Full Text] [Related]
12. Ipratropium bromide: bronchodilator action and effect on methacholine-induced bronchoconstriction.
Larsson K
J Asthma; 1987; 24(1):29-35. PubMed ID: 2975285
[TBL] [Abstract][Full Text] [Related]
13. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children.
Sly PD; Landau LI; Olinsky A
Thorax; 1987 May; 42(5):357-60. PubMed ID: 2958950
[TBL] [Abstract][Full Text] [Related]
14. Preservatives in bronchodilator nebuliser solutions.
Summers Q; Tarala R
Lancet; 1989 Sep; 2(8665):740-1. PubMed ID: 2570983
[No Abstract] [Full Text] [Related]
15. Effect of preservative on the efficacy of terbutaline nebuliser solution in atopic asthma.
Lai CK; Chan CH
Thorax; 1993 May; 48(5):566-8. PubMed ID: 8322247
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of inhaled ipratropium bromide and salbutamol on the bronchoconstrictor response to hypocapnic hyperventilation in normal subjects.
Jamison JP; Glover PJ; Wallace WF
Thorax; 1987 Oct; 42(10):809-14. PubMed ID: 2962333
[TBL] [Abstract][Full Text] [Related]
17. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.
Higgins BG; Powell RM; Cooper S; Tattersfield AE
Eur Respir J; 1991 Apr; 4(4):415-20. PubMed ID: 1830277
[TBL] [Abstract][Full Text] [Related]
18. Bronchoconstriction by nebulized metabisulfite solutions (SO2) and its modification by ipratropium bromide.
Seale JP; Temple DM; Tennant CM
Ann Allergy; 1988 Sep; 61(3):209-13. PubMed ID: 2970816
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the bronchodilatation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination.
Shneerson JM
Respiration; 1986; 50 Suppl 2():274-5. PubMed ID: 2951820
[No Abstract] [Full Text] [Related]
20. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma].
Dor A; Krasnowska M; Małolepszy J
Pneumonol Alergol Pol; 1994; 62(1-2):75-9. PubMed ID: 8075617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
